Why Biotech and Pharma Need GxP for their Digital Transformation Projects Now

Published on: 


Monday December 20, 2021 at 11am EST | 10am CST | 8am PST Pharmaceutical manufacturers are under increasing pressure to fast-track technological innovation while remaining compliant. What are the correct steps to reaching operational intelligence with end-to-end data integrity?

Register free: https://www.pharmtech.com/pt_w/gxp

Event Overview

Pharmaceutical manufacturers are under increasing pressure to fast-track technological innovation to improve their manufacturing operations in order to adapt to new approaches like ‘Industry 4.0’ and continuous manufacturing, combat the growing and intense competition and keep up with the increasing demand for personalized medicine and therapies. But with an industry with the world’s tightest regulations and complex value chains, what are the correct steps to reaching operational intelligence in a GxP compliant manner with end-to-end data integrity?

Key Learning Objectives:

  • How Industry 4.0 technologies like artificial intelligence (AI), machine learning (ML), Internet of Things (IoT), and data lakes used in conjunction can help you integrate and harmonize your data providing a holistic view of your operational environment
  • How to do compliant data acquisition and how safe it is to use AI/ML in a GxP environment and ensure data integrity, encryption, certification, and other key aspects of data management
  • How adopting these technologies result in huge benefits such as decreased downtime and increased productivity

Who Should Attend:

  • Quality Assurance Managers and Regulatory Managers
  • CIO, Chief Data Officers, Chief Digital Officers
  • Pharma and CDMO Manufacturing and Operations
  • Process Engineering
  • Heads of IT or IT Senior Management
  • Pharma 4.0 initiatives


Toni Manzano, Ph.D.
Chief Science Officer and Co-founder

Toni Manzano is a co-founder and Chief Science Officer of Aizon, a SaaS company that is transforming manufacturing operations with the use of AI and IIoT technologies for pharmaceutical and biotech companies. For over two decades, he has led software projects for international pharmaceutical companies covering the entire production process and supply chain. Today, Toni is a part of the scientific committee with PDA Europe and with the AI Xavier Manufacturing team. He worked as a researcher at the University of Barcelona as a physicist and teaches big data and artificial intelligence in postgraduate courses at the UAB. He is also a member of the Science Experts in the Spanish Parliament on big data and artificial intelligence. He has written numerous articles and holds a dozen international patents related to the encryption, transmission, storage, and processing of large volumes of data for regulated environments in the cloud.

Cristina Fernández, Ph.D.
Product Director

Cristina is a scientist with a passion for IT and new technologies. She has a bachelor’s degree in chemistry and holds a Ph.D. in science and technology applied to chemistry with special focus in data analysis (chemometrics). She started her career in pharma in the UK working for AstraZeneca as a process analytical technology (PAT) specialist using spectroscopy to provide process optimization and understanding for pharmaceutical processes in both early and late stage projects enabling scale-up reducing risks. She joined Aizon in early 2018 in quality assurance providing guidelines and training to developers about quality and compliance in pharmaceutical environments. Currently, she is the product owner and ensures the Pharma 4.0 technologies developed are ready to be used in GxP environments.

Register free: https://www.pharmtech.com/pt_w/gxp